Tilray Brands Reports Historic Quarterly Revenue Amid Strategic Shift

Tilray Brands has announced financial results for its second fiscal quarter of 2026, achieving a record high in quarterly revenue. The company’s strategic push into international cannabis markets served as the primary catalyst for this performance. As Tilray continues to diversify its operations across beverage and pharmaceutical segments, it also managed to significantly narrow its net loss. The question for investors is whether this momentum can be sustained throughout the remainder of the fiscal year.

Beyond the top-line growth, the company demonstrated marked improvements in its bottom line. The adjusted EBITDA reached $8.4 million. Management successfully reduced the net loss by 49% year-over-year to $43.5 million. Operational cash flow also saw a substantial improvement, increasing by $32.2 million.

The balance sheet remains robust, with Tilray holding $291.6 million in cash and marketable securities as of the quarter’s close. This position gives the company a liquidity advantage, with cash reserves exceeding its total debt by approximately $30 million.

Segment Performance and Growth Catalysts

The record net revenue of $217.5 million, reported on January 8, 2026, represents the highest second-quarter sales in the corporation’s history. A breakdown by business unit reveals the contributions of its diversified portfolio:

Should investors sell immediately? Or is it worth buying Tilray?

• Distribution Business: $85.3 million (a 26% annual increase)
• Cannabis Operations: $67.5 million
• Beverage Division: $50.1 million
• Wellness Segment: $14.6 million

The international cannabis segment stood out as a particularly powerful engine for expansion, with revenue climbing 36% compared to the prior year to $20 million. The Canadian adult-use market also contributed positively, registering growth of 6%.

Forward Strategy and Market Positioning

Company leadership outlined a strategic pivot in its supply chain approach. The plan involves shifting existing inventory and new production capacity away from the Canadian wholesale market toward higher-margin international opportunities. Tilray believes it is well-positioned for this shift, boasting an annual cultivation capacity of 200 metric tons.

Furthermore, the firm reaffirmed its full-year 2026 guidance, anticipating an adjusted EBITDA in the range of $62 million to $72 million. Investors should note that a 1-for-10 reverse stock split was executed in late 2025, reducing the count of outstanding shares to approximately 116 million. The market will be watching for the next quarterly results, expected around mid-April 2026, to assess the early impact of this renewed international focus.